Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol

Danielle Fredman, Yulia Volchek, MD, Gabriel Heering, Keren Shichrur, PhD, Ronit Yerushalmi, MD, Noga Shem-Tov, MD, Elena Ribakovsky, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, MD, Jonathan Canaani, MD

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134771

Published: 2020

Journal Articles

A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Jonathan Canaani, MD, Ivetta Danilesko, MD, Noga Shem-Tov, MD, Maya Zlotnick, MD, Kira Lozinsky, Ohad Benjamini, Ronit Yerushalmi, MD, Meital Nagar, PhD, Chen Dor, PhD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-135947

Published: 2020

Journal Articles

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Ohad Benjamini, Avichai Shimoni, MD, Michal Besser, PhD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Drorit Grizim Merkel, MD, Tamar Tadmor, MD, David Lavie, MD, Riva Fineman, MD, Elad Jacobi, MD, Arnon Nagler, MD, Abraham Avigdor, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-138904

Published: 2020

Journal Articles

Immunophenotyping and Function of Peripheral Blood Mononuclear Cells in Patients Undergoing Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide in Combination with ATG Anti-Graft Versus Host Disease Prophylaxis

Katia Beider, Valeria Voevoda, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Ivetta Danilesko, MD, Ania Hava Grushchenko-Polaq, Olivia Devillers, Idit Wolf, Olga Ostrovsky, PhD, Avichai Shimoni, MD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 1989.

https://doi.org/10.1182/blood-2019-129619

Published: 2019

Journal Articles

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Joshua A Fein, MD, Avichai Shimoni, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Guy Chowers, MD, Zachary Cohen, Arnon Nagler, MD MSc, Roni Shouval

Blood (2019) 134 (Supplement_1): 4489.

https://doi.org/10.1182/blood-2019-126325

Published: 2019

Journal Articles

Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients

Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2019) 134 (Supplement_1): 3302.

https://doi.org/10.1182/blood-2019-129966

Published: 2019

Journal Articles

Lactate Dehydrogenase Is a Key Prognostic Factor in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Mika Geva, Roni Shouval, Joshua A Fein, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3304.

https://doi.org/10.1182/blood-2019-125529

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Noga Shem-Tov, MD, Christophe Peczynski, Myriam Labopin, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Hélène Labussière-Wallet, Gérard Socié, MDPhD, Nicolaus Kröger, MD, Per Ljungman, MD PhD, Boris Afanasyev, Patrice Chevallier, MD, Johanna Tischer, Grzegorz Helbig, Pavel Jindra, MD PhD, Sebastian Giebel, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2018-99-111604

Published: 2018

Journal Articles

Comorbidity-Driven Risk across Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation

Joshua Fein, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Ivetta Danylesko, Nadav Furie, MD, Arie Apel, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Roni Shouval

Blood (2017) 130 (Supplement 1): 1933.

https://doi.org/10.1182/blood.V130.Suppl_1.1933.1933

Published: 2017

Journal Articles

Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis

Roni Shouval, Liza Kouniavsky, Joshua Fein, Ivetta Danylesko, Arie Apel, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3239.

https://doi.org/10.1182/blood.V130.Suppl_1.3239.3239

Published: 2017

Journal Articles

Carfilzomib in Addition to Standard Cyclosporine/Methotrexate Combination Effectively Prevents Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Avichai Shimoni, MD, Noga Shem-Tov, MD, Ivetta Danilesko, MD, Arie Apel, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3247.

https://doi.org/10.1182/blood.V130.Suppl_1.3247.3247

Published: 2017

Journal Articles

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Ivetta Danylesko, Roni Shouval, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Arie Apel, MD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3263.

https://doi.org/10.1182/blood.V130.Suppl_1.3263.3263

Published: 2017

Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD

Blood (2016) 128 (22): 5429.

https://doi.org/10.1182/blood.V128.22.5429.5429

Published: 2016

Journal Articles

Objective Measures of Pre-Transplant Physiologic Fitness Are Strong Predictors of Very-Short Term Transplantation Related Mortality

Joshua A Fein, Roni Shouval, MD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Vered Dulberg, MD, Maya Muchnick, MD, Shalom Hassid, Ramit Mehr, PhD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2016) 128 (22): 2205.

https://doi.org/10.1182/blood.V128.22.2205.2205

Published: 2016

Journal Articles

Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse after Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Noga Shem-Tov, MD, Francesco Saraceni, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2015) 126 (23): 4346.

https://doi.org/10.1182/blood.V126.23.4346.4346

Published: 2015

Journal Articles

The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Ronit Yerushalmi, MD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2015) 126 (23): 1942.

https://doi.org/10.1182/blood.V126.23.1942.1942

Published: 2015

Journal Articles

Missing HLA C Group 1 Ligand In Patients With AML and MDS Is Associated With Reduced Risk Of Relapse After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

Avichai Shimoni, MD, Massimo Bernardi, MD, Ronit Yerushalmi, MD, Jacopo Peccatori, MD, Noga Shem-Tov, MD, Alessandro Lo Russo, MD, Yulia Volchek, MD, Luca Vago, MD, PhD, Chiara Bonini, MD, Maria Teresa Lupo Stanghellini, MD, Arnon Nagler, MD, MSc, Fabio Ciceri

Blood (2013) 122 (21): 4634.

https://doi.org/10.1182/blood.V122.21.4634.4634

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation In AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: 10 Years Later

Avichai Shimoni, MD, Noga Shem-Tov, MD, Yulia Volchek, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD, MSc

Blood (2013) 122 (21): 4635.

https://doi.org/10.1182/blood.V122.21.4635.4635

Published: 2013

Journal Articles

Chemotherapy Dose Adjustment For Obese Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Survey On Behalf Of The ALWP Of The EBMT

Noga Shem-Tov, MD, Myriam Labopin, MD, Leila Moukhtari, Fabio Ciceri, Jordi Esteve, MD, PhD, Sebastian Giebel, MD, Norbert-Claude Gorin, MD, PhD, Hansjoerg Schmid, Avichai Shimoni, MD, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 4535.

https://doi.org/10.1182/blood.V122.21.4535.4535

Published: 2013

Journal Articles

The Use Of Tevagrastim (Biosimilar Filgrastim XMO2) For Hematopoietic Stem Cell Mobilization In HLA Matched Sibling Donors For Allogeneic Stem Cell Transplantation To AML/MDS Patients

Ivetta Danylesko, MD, Rina Sareli, Nira Bloom-Varda, Ronit Yerushalmi, Noga Shem-Tov, MD, Yulia Volchek, MD, Avichai Shimoni, MD, Arnon Nagler, MD, MSc

Blood (2013) 122 (21): 3275.

https://doi.org/10.1182/blood.V122.21.3275.3275

Published: 2013

NARROW

Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol

A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Immunophenotyping and Function of Peripheral Blood Mononuclear Cells in Patients Undergoing Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide in Combination with ATG Anti-Graft Versus Host Disease Prophylaxis

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients

Lactate Dehydrogenase Is a Key Prognostic Factor in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Comorbidity-Driven Risk across Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation

Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis

Carfilzomib in Addition to Standard Cyclosporine/Methotrexate Combination Effectively Prevents Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Objective Measures of Pre-Transplant Physiologic Fitness Are Strong Predictors of Very-Short Term Transplantation Related Mortality

Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse after Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Missing HLA C Group 1 Ligand In Patients With AML and MDS Is Associated With Reduced Risk Of Relapse After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

Allogeneic Hematopoietic Stem-Cell Transplantation In AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: 10 Years Later

Chemotherapy Dose Adjustment For Obese Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Survey On Behalf Of The ALWP Of The EBMT

The Use Of Tevagrastim (Biosimilar Filgrastim XMO2) For Hematopoietic Stem Cell Mobilization In HLA Matched Sibling Donors For Allogeneic Stem Cell Transplantation To AML/MDS Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only